Skip to main content
. 2021 Nov 26;21(6):479–506. doi: 10.17245/jdapm.2021.21.6.479

Fig. 6. Subgroup analyses for differences in post-treatment SF-36 subscales with (a) THC/CBD and (b) dronabinol. Higher SF-36 scores represent favorable quality of life. CBD, cannabidiol; CI, confidence interval; SF-36, 36 item short form survey; THC, tetrahydrocannabinol.

Fig. 6